Literature DB >> 3631312

Use of caffeine to lengthen seizures in ECT.

P E Hinkle, C E Coffey, R D Weiner, M Cress, C Christison.   

Abstract

During a course of ECT, seizure duration may become too brief for clinical benefit. Use of higher-energy stimuli may lengthen seizures but may also increase the risk of toxicity, and it is not possible when maximum settings are reached. The authors present the cases of six drug-free depressed inpatients whose seizure durations in ECT declined despite maximum settings on three different ECT devices. In all cases, pretreatment with caffeine lengthened seizures (mean increase = 107%), and clinical improvement followed. Caffeine was well tolerated, even in patients with cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3631312     DOI: 10.1176/ajp.144.9.1143

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  2 in total

Review 1.  The Use of Caffeine by People with Epilepsy: the Myths and the Evidence.

Authors:  Prisca R Bauer; Josemir W Sander
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-14       Impact factor: 5.081

Review 2.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.